ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

In Brief: NCI to Extend Frederick contract To SAIC; Klausner, Gallin, Gail Elected to IOM

October 24, 1996

Mothers’ Smoking, Depression Influences Teen Smoking

May 28, 2010

PET Better At Evaluating Response In Sarcoma

February 29, 2008

White House Defers to Pressure, Gives Up Attempt to Cut NIH Budget $334 Million In ‘87

March 6, 1987

CT Screening for Lung Cancer Unproven; Limit Use to Trials, Chest Physicians Urge.

September 14, 2007